These observed effects of resveratrol, FAK- inhibition and CytD in HCT116 and SW480 CRC cells highlight the involvement of cytoskeletal signaling molecules in resveratrol-mediated anti-tumorigenic effects. The gene discussed is PTK2; the disease is colorectal carcinoma.